Evvy, women-founded healthtech startup has announced the closing of a $14 million Series A funding round led by Left Lane Capital. The company is focused on unlocking precision women’s healthcare through biomarker discovery.
Since its launch in July 2021, Evvy has launched an at-home vaginal microbiome test, generated a comprehensive data set on the vaginal microbiome and launched its AI-powered vaginal healthcare platform. The company wants to transform how people understand and care for the female body and ultimately close the gender health gap through state-of-the-art testing, precision care and proactive tracking.
Evvy will use its new funding to scale access to its testing and care platform, leverage AI to discover novel molecular signatures as well as validate improved outcomes in fertility, pregnancy and other areas.
